Health
Inhaled nebulized interferon beta-1a (SNG001) helps COVID-19 patients recovers – News-Medical.Net
Now, a team of researchers at the Synairgen Research, Southampton General Hospital, Southampton, United Kingdom, has found that inhaled nebulized interferon beta-1a…
Amid the coronavirus disease (COVID-19) pandemic, scientists and health experts race to develop drugs and vaccines against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Many scientists resorted to repurposing approved drugs to be used on infected patients to help them recover.
Now, a team of researchers at the Synairgen Research, Southampton General Hospital, Southampton, United Kingdom, has found that inhaled nebulized interferon beta-1a (SNG001), a drug used for multiple sclerosis,…
-
Business15 hours ago1 ASX dividend stock down 43% I’d buy right now
-
Noosa News15 hours agoBanana farmers still salvaging fruit four weeks after ex-Tropical Cyclone Alfred
-
Noosa News14 hours agoQueen Street Mall to get a 3D digital billboard; Dutton dumps controversial plans to end flexible work; Measles alert for tourist hotspots
-
Business19 hours agoBattle of the ASX ETFs: Why has VGS outperformed VTS this year?